Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
How is the Smart Biopsy Devices Market size predicted to change over the forecast window of 2026–2035?
The smart biopsy devices market size has demonstrated robust growth in recent years. Its value is forecast to expand from $3.01 billion in 2025 to $3.23 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. This historical growth can be linked to factors such as an increase in cancer incidence rates, the growing adoption of minimally invasive diagnostic procedures, the expansion of advanced imaging infrastructure, the wider use of core needle biopsy techniques, and better clinician training in image-guided diagnostics.
The smart biopsy devices market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a value of $4.32 billion, demonstrating a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period is largely driven by factors such as the heightened need for precision oncology diagnostics, increased capital allocation towards smart surgical innovations, the broader availability of robotic-assisted intervention platforms, a heightened emphasis on detecting diseases at earlier stages, and the greater incorporation of AI-powered diagnostic assistance. Prominent developments expected in this period encompass the wider acceptance of image-guided biopsy systems, the growing deployment of robotic-assisted biopsy procedures, the increasing incorporation of real-time tissue feedback technologies, the broader application of minimally invasive diagnostic methods, and an intensified commitment to diagnostic accuracy and patient safety.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp
Which Drivers Are Contributing To The Expansion Of The Smart Biopsy Devices Market?
The anticipated increase in cancer incidents is set to propel the expansion of the smart biopsy devices market. Cancer encompasses a wide range of diseases, characterized by abnormal cell proliferation in almost any body part, leading to uncontrolled growth, boundary transgression, and potential spread or invasion of adjacent tissues. The growing incidence of cancer has escalated the demand for highly accurate and targeted tissue samples. Consequently, this has spurred the development and enhancement of smart biopsy instruments, which offer improved molecular analysis, imaging, and precision for diagnostic purposes and treatment strategy formulation. For example, according to the World Health Organization, a Switzerland-based Intergovernmental organization, in January 2024, it was projected that there will be over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases and 9.7 million deaths recorded in 2022. Therefore, the escalating prevalence of cancer is a key driver for the smart biopsy device market’s growth.
What Segment Classifications Make Up The Smart Biopsy Devices Market?
The smart biopsy devices market covered in this report is segmented –
1) By Product: Needle-Based Biopsy Instruments, Localization Wires
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
2) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices
What Long-Term Trends Are Expected To Shape The Future Of The Smart Biopsy Devices Market?
Leading companies within the smart biopsy devices market are prioritizing the development of advanced solutions, such as multi-modality breast biopsy markers. These efforts aim to enhance lesion localization, ensure long-term visibility of biopsy sites, and bolster diagnostic confidence. Multi-modality markers are specialized biopsy site indicators crafted to remain clearly identifiable across ultrasound, mammography, and MRI, aiding clinicians in accurately tracking biopsy locations and supporting precise follow-up assessments. For instance, in March 2024, Mammotome, a U.S.-based medical technology company, released LumiMARK, its next-generation 510(k)-cleared breast biopsy site marker tailored for multi-modality identification. Available in three distinct 3D shapes—including Tulip™ and Rose™—the marker guarantees consistent visibility across various imaging modalities and provides improved long-term detectability in both breast tissue and lymph nodes, facilitating more accurate diagnosis and continuous clinical decision-making.
Which Key Players Are Driving Competition In The Smart Biopsy Devices Market?
Major companies operating in the smart biopsy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Cook Medical Inc., Medtronic Plc, Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG, Stryker Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The Smart Biopsy Devices Market?
North America was the largest region in the smart biopsy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Smart Biopsy Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp
Browse Through More Reports Similar to the Global Smart Biopsy Devices Market 2026, By The Business Research Company
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Patient Monitoring Devices Market 2026
https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company